Excellergy, a new company in the pharmaceutical field, has recently raised $70 million in its first major funding round. This has allowed them to make significant progress in their work. They are now planning to start the first tests of their main product in humans. These tests are an important step in developing new medicines, as they help to see if a treatment is safe and effective in people. Excellergy is working hard to bring new and innovative treatments to patients. Stay informed about the latest news and developments in the pharmaceutical industry to give your business an edge.